BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34141907)

  • 1. Analysis of fertility clinic marketing of complementary therapy add-ons.
    Stein J; Harper JC
    Reprod Biomed Soc Online; 2021 Aug; 13():24-36. PubMed ID: 34141907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence, promotion and pricing of three IVF add-ons on fertility clinic websites.
    van de Wiel L; Wilkinson J; Athanasiou P; Harper J
    Reprod Biomed Online; 2020 Nov; 41(5):801-806. PubMed ID: 32888824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVF add-ons in Australia and New Zealand: A systematic assessment of IVF clinic websites.
    Lensen S; Chen S; Goodman L; Rombauts L; Farquhar C; Hammarberg K
    Aust N Z J Obstet Gynaecol; 2021 Jun; 61(3):430-438. PubMed ID: 33594674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claims for fertility interventions: a systematic assessment of statements on UK fertility centre websites.
    Spencer EA; Mahtani KR; Goldacre B; Heneghan C
    BMJ Open; 2016 Nov; 6(11):e013940. PubMed ID: 27890866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VALUE study: a protocol for a qualitative semi-structured interview study of IVF add-ons use by patients, clinicians and embryologists in the UK and Australia.
    Armstrong SC; Lensen S; Vaughan E; Wainwright E; Peate M; Balen AH; Farquhar CM; Pacey A
    BMJ Open; 2021 May; 11(5):e047307. PubMed ID: 34020980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Add-Ons" for Assisted Reproductive Technology: Do Patients Get Honest Information from Fertility Clinics' Websites?
    Galiano V; Orvieto R; Machtinger R; Nahum R; Garzia E; Sulpizio P; Marconi AM; Seidman D
    Reprod Sci; 2021 Dec; 28(12):3466-3472. PubMed ID: 33939166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.
    Murdoch B; Zarzeczny A; Caulfield T
    BMJ Open; 2018 Feb; 8(2):e019414. PubMed ID: 29490963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients.
    Lensen S; Hammarberg K; Polyakov A; Wilkinson J; Whyte S; Peate M; Hickey M
    Hum Reprod; 2021 Jun; 36(7):1854-1861. PubMed ID: 33942073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passion, pressure and pragmatism: how fertility clinic medical directors view IVF add-ons.
    Iacoponi O; van de Wiel L; Wilkinson J; Harper JC
    Reprod Biomed Online; 2022 Jul; 45(1):169-179. PubMed ID: 35537928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "It all depends on why it's red": qualitative interviews exploring patient and professional views of a traffic light system for IVF add-ons.
    Lensen S; Armstrong S; Vaughan E; Caughey L; Peate M; Farquhar C; Pacey A; Balen AH; Wainwright E
    Reprod Fertil; 2023 May; 4(2):. PubMed ID: 37140974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethics and IVF add-ons: We need to talk about it.
    Braga DPAF; Setti AS; Borges E
    JBRA Assist Reprod; 2022 Aug; 26(3):371-373. PubMed ID: 35930629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysing adherence to guidelines for time-lapse imaging information on UK fertility clinic websites.
    Perrotta M; Zampino L; Geampana A; Bhide P
    Hum Fertil (Camb); 2024 Dec; 27(1):2346595. PubMed ID: 38769878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessing publicly funded donor insemination treatment in the UK: is funding information available on fertility clinic websites?
    Taylor F; Turner-Moore R; Pacey A; Jones G
    Hum Fertil (Camb); 2023 Jul; 26(3):512-518. PubMed ID: 37161825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the use of IVF add-on treatments driven by patients or clinics? Findings from a UK patient survey.
    Cirkovic S; Wilkinson J; Lensen S; Jackson E; Harper J; Lindemann K; Costa-Font J
    Hum Fertil (Camb); 2023 Dec; 26(2):365-372. PubMed ID: 37063051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-to-consumer advertising of success rates for medically assisted reproduction: a review of national clinic websites.
    Wilkinson J; Vail A; Roberts SA
    BMJ Open; 2017 Jan; 7(1):e012218. PubMed ID: 28082363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low E-visibility of embryologists on fertility clinic websites: a web-based cross-sectional study.
    Choucair F; Atilan O; Almohammadi A; Younis N; Al Hourani A; Curchoe CL; Raad G
    J Assist Reprod Genet; 2023 Nov; 40(11):2619-2626. PubMed ID: 37715874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good practice recommendations on add-ons in reproductive medicine†.
    ; Lundin K; Bentzen JG; Bozdag G; Ebner T; Harper J; Le Clef N; Moffett A; Norcross S; Polyzos NP; Rautakallio-Hokkanen S; Sfontouris I; Sermon K; Vermeulen N; Pinborg A
    Hum Reprod; 2023 Nov; 38(11):2062-2104. PubMed ID: 37747409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Baby at All Costs? Exploring the Use and Provision of Unproven Adjuvant Treatments in the Context of IVF.
    Jones GL; Lang V; Hudson N
    Semin Reprod Med; 2021 Nov; 39(5-06):220-226. PubMed ID: 34500475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The marketing of elective egg freezing: A content, cost and quality analysis of UK fertility clinic websites.
    Gürtin ZB; Tiemann E
    Reprod Biomed Soc Online; 2021 Mar; 12():56-68. PubMed ID: 33336090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The crafting of hope: Contextualising add-ons in the treatment trajectories of IVF patients.
    Perrotta M; Hamper J
    Soc Sci Med; 2021 Oct; 287():114317. PubMed ID: 34492406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.